睿智医药科技股份有限公司 Reviews

Company Overview

Nature: 上市公司 Size: 5000-9999人 Founded: 26年
Industry: 制药/生物工程、学术/科研
Full name: 睿智医药科技股份有限公司。

Development Stage

Stage: IPO上市，创业板，深交所。
Ranking: Ranked #6 in 江门临床医学公司 by popularity Ranked #12 in 江门医药公司 by popularity Ranked #12 in 江门生物科技/生物工程公司 by popularity Ranked #12 in 江门生物科技公司 by popularity
Honors: 2023中国生命科学服务100强高新技术企业省级高新技术企业 According to algorithm

About the Company

[Summary] 专注医药研发与生产服务外包及微生态医疗领域

睿智医药科技股份有限公司系一家领先的医药研发外包服务机构CROCDMO业务,秉持科技为本,技术为先、全球运营、卓越品质的发展理念,致力于持续为全球医药健康产业创新赋能。为全球制药企业、生物技术研发公司及科研院校提供涵盖生物药及化学药的临床前研发CRO业务与临床药物开发生产CDMO的新药研发生产一体化服务。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

睿智医药 Financing History (1 rounds)

Manage

IPO上市

Capital Market Favor

Latest Financing Round

Date: ?
Market: 创业板
Deal: 深交所

睿智医药 Recruitment Overview / Current Status (134 open positions)

Manage

上海 114 南昌 8 南通 5 成都 2 南京 1

睿智医药 Campus Recruitment & Advanced Degree Talent Demand

Graduates 22 Interns 13 Master's 25 Doctorate 15

No.1

Graduate Talent Ranking in 江门 򀀩

No.1

Intern Talent Ranking in 江门 򀀩

睿智医药 Latest Jobs

Note: How fast is hiring at 睿智医药科技股份有限公司 growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.